FILE PHOTO: The Walmart logo in New York, U.S., May 1, 2018. REUTERS/Brendan McDermid/File Photo
(Reuters) – IBM Corp, Merck & Co, KPMG and Walmart Inc said on Thursday they will be a part of U.S. Food and Drug Administration’s pilot program that will explore using blockchain to identify, track and trace prescription drugs.
The companies said they would create a shared blockchain network to allow real-time monitoring of products in the pharmaceutical supply chain.
Reporting by Tamara Mathias in Bengaluru; Editing by Shinjini Ganguli